New York still has a lot to work out as their adult-use market finally launches
Dozens of entrepreneurs are on the sidelines waiting – and hoping – for regulatory approval to begin operations in New York, reports MJ Biz Daily.
With just one operational shop, and with New York’s illicit market still strong, the publication highlights that the state still has a lot of work to do to fulfill its potential as one of the biggest cannabis markets in the country.
“The more dispensaries we open, as well as those other enforcement actions, is what’s going to create the push for folks to transition from the illicit to the regulated market,” said Chris Alexander, the executive director of New York’s Office of Cannabis Management.
SOCIAL EQUITY
New cannabis incubator program launches
Benzinga writes that the 1937 Group is launching a Cannabis Incubator Program to help members of the community apply for a social equity license.
The incubator will offer a range of resources and assistance including:
● Business formation
● Legal templates/agreements
● Documentation review
● Dispensary site selection
● Standard Operating Procedures (SOPs)
● Investor connections
● Marketing planning and development
● Supply chain strategy
PART 2
What’s in store for the European cannabis industry in 2023?
In part two of two, BusinessCann explores the coming year for the European cannabis industry.
The publication shares insights from prominent voices in the industry including the Cannabis Industry Council, Enexis AB, Cannavigia, Ananda Developments, Mull Cafe and the Hemp Hound Agency.
Some predictions include:
- Economic pressures will mean capital available for the European cannabis industry will be ‘scarce’ in the first half of 2023; however, this will begin to ‘rebound thereafter’.
- Industry players still have the chance to shape the regulatory framework of the future and support policymakers in their decisions.
- Could see regulatory change in the UK which helps to clear the path to making medical cannabis a better recognised, more readily prescribed medicine in the country.
New York still has a lot to work out as their adult-use market finally launches
Dozens of entrepreneurs are on the sidelines waiting – and hoping – for regulatory approval to begin operations in New York, reports MJ Biz Daily.
With just one operational shop, and with New York’s illicit market still strong, the publication highlights that the state still has a lot of work to do to fulfill its potential as one of the biggest cannabis markets in the country.
“The more dispensaries we open, as well as those other enforcement actions, is what’s going to create the push for folks to transition from the illicit to the regulated market,” said Chris Alexander, the executive director of New York’s Office of Cannabis Management.
SOCIAL EQUITY
New cannabis incubator program launches
Benzinga writes that the 1937 Group is launching a Cannabis Incubator Program to help members of the community apply for a social equity license.
The incubator will offer a range of resources and assistance including:
● Business formation
● Legal templates/agreements
● Documentation review
● Dispensary site selection
● Standard Operating Procedures (SOPs)
● Investor connections
● Marketing planning and development
● Supply chain strategy
PART 2
What’s in store for the European cannabis industry in 2023?
In part two of two, BusinessCann explores the coming year for the European cannabis industry.
The publication shares insights from prominent voices in the industry including the Cannabis Industry Council, Enexis AB, Cannavigia, Ananda Developments, Mull Cafe and the Hemp Hound Agency.
Some predictions include:
- Economic pressures will mean capital available for the European cannabis industry will be ‘scarce’ in the first half of 2023; however, this will begin to ‘rebound thereafter’.
- Industry players still have the chance to shape the regulatory framework of the future and support policymakers in their decisions.
- Could see regulatory change in the UK which helps to clear the path to making medical cannabis a better recognised, more readily prescribed medicine in the country.
New York still has a lot to work out as their adult-use market finally launches
Dozens of entrepreneurs are on the sidelines waiting – and hoping – for regulatory approval to begin operations in New York, reports MJ Biz Daily.
With just one operational shop, and with New York’s illicit market still strong, the publication highlights that the state still has a lot of work to do to fulfill its potential as one of the biggest cannabis markets in the country.
“The more dispensaries we open, as well as those other enforcement actions, is what’s going to create the push for folks to transition from the illicit to the regulated market,” said Chris Alexander, the executive director of New York’s Office of Cannabis Management.
SOCIAL EQUITY
New cannabis incubator program launches
Benzinga writes that the 1937 Group is launching a Cannabis Incubator Program to help members of the community apply for a social equity license.
The incubator will offer a range of resources and assistance including:
● Business formation
● Legal templates/agreements
● Documentation review
● Dispensary site selection
● Standard Operating Procedures (SOPs)
● Investor connections
● Marketing planning and development
● Supply chain strategy
PART 2
What’s in store for the European cannabis industry in 2023?
In part two of two, BusinessCann explores the coming year for the European cannabis industry.
The publication shares insights from prominent voices in the industry including the Cannabis Industry Council, Enexis AB, Cannavigia, Ananda Developments, Mull Cafe and the Hemp Hound Agency.
Some predictions include:
- Economic pressures will mean capital available for the European cannabis industry will be ‘scarce’ in the first half of 2023; however, this will begin to ‘rebound thereafter’.
- Industry players still have the chance to shape the regulatory framework of the future and support policymakers in their decisions.
- Could see regulatory change in the UK which helps to clear the path to making medical cannabis a better recognised, more readily prescribed medicine in the country.

OHIO REFORMS
Ohio lawmakers given four months to consider cannabis reform
Ohio’s secretary of State Frank LaRose (R) has formally resubmitted an activist-led cannabis legalization petition to the legislature, giving lawmakers four months to consider the reform, writes Marijuana Moment.
LaRose said that if they don’t act, advocates could then collect additional signatures to place the issue on the November ballot for voters to decide on.
Tom Haren, a spokesperson for the campaign, told Marijuana Moment: “The Coalition to Regulate Marijuana Like Alcohol is pleased that our proposal was re-transmitted to the Ohio General Assembly and that the Secretary of State clarified that the General Assembly’s four-month clock to consider our proposal has begun.”
New York still has a lot to work out as their adult-use market finally launches
Dozens of entrepreneurs are on the sidelines waiting – and hoping – for regulatory approval to begin operations in New York, reports MJ Biz Daily.
With just one operational shop, and with New York’s illicit market still strong, the publication highlights that the state still has a lot of work to do to fulfill its potential as one of the biggest cannabis markets in the country.
“The more dispensaries we open, as well as those other enforcement actions, is what’s going to create the push for folks to transition from the illicit to the regulated market,” said Chris Alexander, the executive director of New York’s Office of Cannabis Management.
SOCIAL EQUITY
New cannabis incubator program launches
Benzinga writes that the 1937 Group is launching a Cannabis Incubator Program to help members of the community apply for a social equity license.
The incubator will offer a range of resources and assistance including:
● Business formation
● Legal templates/agreements
● Documentation review
● Dispensary site selection
● Standard Operating Procedures (SOPs)
● Investor connections
● Marketing planning and development
● Supply chain strategy
PART 2
What’s in store for the European cannabis industry in 2023?
In part two of two, BusinessCann explores the coming year for the European cannabis industry.
The publication shares insights from prominent voices in the industry including the Cannabis Industry Council, Enexis AB, Cannavigia, Ananda Developments, Mull Cafe and the Hemp Hound Agency.
Some predictions include:
- Economic pressures will mean capital available for the European cannabis industry will be ‘scarce’ in the first half of 2023; however, this will begin to ‘rebound thereafter’.
- Industry players still have the chance to shape the regulatory framework of the future and support policymakers in their decisions.
- Could see regulatory change in the UK which helps to clear the path to making medical cannabis a better recognised, more readily prescribed medicine in the country.
Related Posts
Related Posts
Kanabo Calls in Administrators, Marking Sobering End to LSE Cannabis Rush
UK medical cannabis operator Kanabo Group has fallen into administration, seeing the last remaining member of the first four cannabis...
High Tide Opens First European Retail Location in Berlin
High Tide Inc. (Nasdaq: HITI) has opened its first international Canna Cabana store in Berlin, Germany, marking the cannabis retailer's...
CONNECT
Related Posts
Related Posts
First Practical Medical Cannabis Oil Dosing Guide Published for UK Clinicians
Originally published on Cannabis Health The Medical Cannabis Clinicians Society (MCCS) has published what it describes as a crucial step...
Medicare CBD Coverage Proposed, But Federal Ban Threatens Entire Industry
Cannabis stocks enjoyed another spike last week following reports that the Centers for Medicare & Medicaid Services is preparing to...
Kanabo Calls in Administrators, Marking Sobering End to LSE Cannabis Rush
UK medical cannabis operator Kanabo Group has fallen into administration, seeing the last remaining member of the first four cannabis...
High Tide Opens First European Retail Location in Berlin
High Tide Inc. (Nasdaq: HITI) has opened its first international Canna Cabana store in Berlin, Germany, marking the cannabis retailer's...
Ananda Exits Landmark NHS-Funded Epilepsy Trial and Public Markets
Ananda Pharma, one of the UK's leading clinical-stage pharmaceutical cannabis companies, has announced a string of strategic pivots, including stepping...
Recent Posts
Related Posts
How New York’s Next Mayor Will Shape the Future of Cannabis in the State
As New Yorkers prepare to head to the polls to vote for their new Mayor tomorrow (Tuesday, November 04), the...
Countdown to Business of Cannabis: New York 2025, Celebrating Our Pioneering Sponsors
Next Thursday, 6 November 2025, Business of Cannabis: New York returns to The Wythe Hotel, Williamsburg, uniting more than 300...
Evidence, Earnings and Expansion: Avextra Enrolls its First Patient to Landmark Italian Clinical Trial, as Market Leaders Wrangle to Maintain Dominance
The European medical cannabis industry is continuing to mature, seeing companies focused on science-based research push the boundaries of our...
Speculation to Selectivity: Renewed Optimism Emerges Across Cannabis and Biotech Plays
Tilray Tilray has enjoyed a series of significant bumps in stock price over the last couple of weeks, driven largely...
California Medical Cannabis Home Delivery Bill Vetoed by Governor Newsom
California Governor Gavin Newsom has vetoed legislation that would have allowed certain cannabis microbusinesses to ship medical products directly to...
Subscribe to our mailing list to receives daily updates!
We won’t spam you















